Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
09/2012
09/27/2012WO2012129513A2 Blockage of pai-1 in diabetic cd34+ stem cells corrects cellular dysfunction
09/27/2012WO2012129448A1 Methods and compositions for improving antiangiogenic therapy with anti-integrins
09/27/2012WO2012129394A2 Methods and compositions for the treatment of cancer
09/27/2012WO2012129335A2 Hyd1 peptides for relapsed cancer
09/27/2012WO2012128998A2 Method for delivering gene and cell therapy to a tumor or targeted site using an implanted metronomic biofeedback pump
09/27/2012WO2012127739A1 Novel carrier molecule and method both for delivering rna into cytoplasm using near-infrared light
09/27/2012WO2012126369A1 Dna, recombinant vector containing the same, cell, composition and use thereof
09/27/2012WO2012126359A1 A drug carrier for tumor-targeted therapy, its preparation method and its use
09/27/2012WO2012100017A3 Antiretroviral cyclonucleoside compositions and methods and articles of manufacture therewith
09/27/2012WO2012078586A3 Pharmaceutical composition comprising nanog shrna, and method of usnig nanog shrna to treat cancer
09/27/2012US20120246747 Rna-interference by single-stranded rna molecules
09/27/2012US20120246746 Method for Generating Immune-Compatible Cells and Tissues Using Nuclear Transfer Techniques
09/27/2012US20120245221 Anti-apoptotic agents and uses thereof
09/27/2012US20120245220 Nucleic acid molecules and methods for exchanging exon(s) by transsplicing
09/27/2012US20120245092 Polypeptides having modulatory effects on cells
09/27/2012US20120244222 Osmotic mediated release synthetic nanocarriers
09/27/2012US20120244209 Tusc2 therapies
09/27/2012US20120244175 Tumor specific animal proteins
09/27/2012US20120244159 Specific Antibodies To Amyloid Beta Peptide, Pharmaceutical Compositions And Methods Of Use Thereof
09/27/2012US20120244120 Inhibitors of hemopoietic cell kinase (p59-hck) and their use in the treatment of influenza infection
09/26/2012EP2502999A2 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
09/26/2012EP2501414A2 Smndelta7 degron: novel compositions and methods of use
09/26/2012EP2501404A1 Use of newcastle disease virus-based vector for inducing an immune response in mammals
09/26/2012CN1997746B Chimeric adenoviruses for use in cancer treatment
09/26/2012CN1788088B Mutant vesicular stomatitis viruses and use thereof
09/26/2012CN1679929B Streptococcal c5a peptidase vaccine
09/26/2012CN1662663B DNA enzyme to inhibit plasminogen activator inhibitor-1
09/26/2012CN102695797A Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene
09/26/2012CN102695526A Novel viral vector construct for neuron specific optimized continuous DOPA synthesis in vivo
09/26/2012CN102695525A RNA with a combination of unmodified and modified nucleotides for protein expression
09/26/2012CN102690879A Application of CDK17 gene and expression product thereof
09/26/2012CN102690878A Application of CDK18 gene and expression product thereof
09/26/2012CN102690877A Application of CSNK1A1 gene and expression product thereof
09/26/2012CN102690876A Application of CSNK1G3 gene and expression product thereof
09/26/2012CN102690875A Application of CDK14 gene and expression product thereof
09/26/2012CN102690872A Application of TRIM28 gene and its expression product
09/26/2012CN102690871A Application of TEX14 gene and its expression product
09/26/2012CN102690870A Application of STC2 gene and its expression product
09/26/2012CN102690869A Application of MEP1A gene and its expression product
09/26/2012CN102690868A Application of PDK3 gene and its expression product
09/26/2012CN102690867A Application of NLK gene and its expression product
09/26/2012CN102690866A Application of TRPM7 gene and its expression product
09/26/2012CN102690865A MELK gene and application of its expression product
09/26/2012CN102690826A shRNA for specifically reducing human Aurora-A gene expression and application thereof
09/26/2012CN102690353A Method for rapid screening of modified tumor necrosis factor receptor II-adiponectin globular-site fusion protein and application thereof
09/26/2012CN102690335A Polypeptide for effectively inhibiting activity of influenza virus polymerase
09/26/2012CN102688504A Medicinal composition for promoting weight increment of mink
09/26/2012CN102688503A Medical composition for promoting weight gain of fox
09/26/2012CN102688502A Preparation process for gene vaccines containing UreB and CagA protein of helicobacter pylori
09/26/2012CN102688491A MET inhibitors for enhancing radiotherapy efficacy
09/26/2012CN102688488A Mucosal adjuvant and its preparation method and use
09/26/2012CN101934081B Magnetic nano lamellar hydroxyapatite and DNA composite as well as preparation method and application thereof
09/26/2012CN101912617B Application of MG53 gene to treatment of insulin resistance, type II diabetes mellitus and related diseases thereof
09/26/2012CN101886090B Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof
09/26/2012CN101575607B Recombinant BCG vaccine based on human MUC1 repetitive sequence and GM-CSF fusion expression
09/26/2012CN101087623B Antisense oligonucleotides for treating allergy and neoplastic cell proliferation
09/26/2012CN101072792B Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal
09/25/2012US8273866 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SINA)
09/25/2012US8273568 Replication-competent herpes simplex virus mediates destruction of neoplastic cells
09/25/2012US8273548 Nucleic acids encoding a human PAP1 polypeptide
09/25/2012US8273356 Anti-IgE vaccines
09/25/2012US8273344 Plasmid construct comprising cytochrome p450 oxygenase inhibitory oligonucleotides for use in prevention and treatment of cell proliferative disorders
09/25/2012US8273342 Anti-virus therapy for respiratory diseases
09/25/2012CA2664137C Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
09/25/2012CA2522994C Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer
09/25/2012CA2453295C Novel oligoribonucleotide derivatives for specific inhibition of gene expression
09/25/2012CA2428438C Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
09/25/2012CA2229171C Method of modulating gene expression with reduced immunostimulatory response
09/25/2012CA2189778C Use of fas ligand to suppress lymphocyte-mediated immune responses
09/20/2012WO2012125987A2 Delivery system
09/20/2012WO2012125828A2 Methods of treating breast cancer with anthracycline therapy
09/20/2012WO2012125772A2 Oral formulations for promoting cellular purification
09/20/2012WO2012125554A2 Compositions and methods for the treatment of cancer
09/20/2012WO2012125405A2 Methods and materials for assessing responsiveness to lenalidomide, thalidomide, and/or other thalidomide analogs
09/20/2012WO2012124688A1 Vector for pulmonary delivery, inducing agent, and uses
09/20/2012WO2012094512A3 Myocardial tissue targeting peptides
09/20/2012WO2012068341A3 Wnt1 for treatment of cardiovascular disorders and injuries
09/20/2012US20120240247 Jnk3 modulators and methods of use
09/20/2012US20120240245 Methods and compositions for detecting and treating retinal diseases
09/20/2012US20120238500 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
09/20/2012US20120238499 Methods of modulating apoptosis by administration of relaxin agonists or antagonists
09/20/2012US20120237588 Methods of improving cardiac function and attenuating and/or preventing cardiac remodeling with hsp20
09/20/2012US20120237524 Met inhibitors for enhancing radiotherapy efficacy
09/20/2012US20120237521 Compositions and methods for increasing muscle growth
09/20/2012US20120237493 Nucleic acids encoding a mut-t domain-containing polypeptide
09/20/2012CA2830240A1 Methods of treating breast cancer with anthracycline therapy
09/19/2012EP2500431A2 Methods and compositions for reducing viral genome amounts in a target cell
09/19/2012EP2500430A2 Antisense oligonucleotides for inducing exon skipping and methods of use thereof
09/19/2012EP2500030A2 Use of complement pathway inhibitors to treat ocular diseases
09/19/2012EP2499249A1 Antisense molecules and methods for treating pathologies
09/19/2012EP2498825A2 Novel viral vector construct for neuron specific continuous dopa synthesis in vivo
09/19/2012EP2498798A1 Compositions and methods for wound treatment
09/19/2012CN102676554A Eimeria tenella protein tyrosine phosphatase gene and expression method as well as application thereof
09/19/2012CN102676547A Fusion protein containing neutralizing epitope gene of C-terminal of encephalitis-B E protein and vaccine containing fusion protein
09/19/2012CN102676519A Micro ribonucleic acid (RNA) for inhibiting viral multiplication of porcine reproductive and respiratory syndrome and application thereof
09/19/2012CN102676518A Novel anti-tumor amiRNA (artificial micro Ribonucleic Acid) sequence and application thereof
09/19/2012CN102676517A Survivin gene folate receptor targeted novel liposome
09/19/2012CN102676461A Method for producing virus-like particles by utilizing drosophila cells and application
09/19/2012CN102675655A Water-soluble fullerene and preparation and application methods thereof
09/19/2012CN102675471A Pig foot-and-mouth disease virus O-type broad spectrum multi-epitope recombination antigen and application thereof
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 870